C-MIMI: AI automatically generates radiology impressions

SAN FRANCISCO - A deep-learning artificial intelligence (AI) algorithm can...Read more on AuntMinnie.comRelated Reading: JAMA: 7 forces will drive adoption of AI in healthcare AI spots lung nodules on CT, with low false-positive rate 3 ways AI could be integrated into radiology workflow AI, new cardiac imaging technology can assess for CAD AI algorithm can triage head CT exams for urgent review
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Kevin Budding, Jessica van Setten, Eduard A. van de Graaf, Oliver A. van Rossum, Tineke Kardol-Hoefnagel, Johanna M. Kwakkel-van Erp, Erik-Jan D. Oudijk, C. Erik Hack, Henderikus G. Otten
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Despite advances in device technology and treatment strategies infection remains a major cause of adverse events (AE) in mechanical circulatory support (MCS) patients. To characterize the epidemiology of MCS infection we examined the type, location, and timing of infection in the International Society for Heart and Lung Transplantation Registry (ISHLT) for Mechanically Assisted Circulatory Support (IMACS) over 3 years, 2013-2015.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Specialized T cells in induced bronchus-associated lymphoid tissue regulate alloimmune responses in the lung allograft.
Source: Science Translational Medicine - Category: Biomedical Science Authors: Tags: Editors ' Choice Source Type: research
We read with great interest the review by Yanagawa et al, entitled Surgery for tumors of the heart,1 where the authors thoroughly review cardiac tumors classification, diagnosis sequence as well as the suggested method of treatment for the different kinds of tumors. The authors address sarcoma's as one of the rare malignant tumors and suggest a two-step surgical approach to sarcoma that involve the heart and lung.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ADULT – Letter to the Editor Source Type: research
PMID: 30648883 [PubMed - as supplied by publisher]
Source: Am J Respir Cell Mol... - Category: Respiratory Medicine Authors: Tags: Am J Respir Cell Mol Biol Source Type: research
Zerina Nelson, four, of Mesa, Arizona, was diagnosed with Hermansky-Pudlak syndrome, a genetic condition characterized by albinism and vision considered legally blind
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conditions:   Lung Transplant Rejection;   Antibody-mediated Rejection Interventions:   Drug: Belatacept;   Drug: Carfilzomib Sponsors:   Duke University;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
We present a case of endobronchial fusariosis following bilateral sequential lung transplantation for idiopathic pulmonary arterial hypertension in a 13 years old boy who was treated successfully with posaconazole and nebulized amphotericin B. We discuss the role of nebulized amphotericin B in treating invasive pulmonary fungal disease in children. To our knowledge, this is the first pediatric case of endobronchial fusariosis reported in the literature.
Source: Medical Mycology Case Reports - Category: Biology Source Type: research
Chronic lung allograft dysfunction or CLAD, encompasses a variety of phenotypes including both obstructive and restrictive phenotypes as detected by pulmonary function testing (PFTs), and has advanced the understanding of current clinical guidelines1-5. From the initial classification of chronic lung allograft rejection based primarily on pulmonary function testing, clinical guidelines now encompass CLAD phenotypes, presumed causes, characteristic imaging findings, and refinement of histopathological grades.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research
Born at 27 weeks, twin babies Irie and Judah Felkner of Columbus, Ohio, were both fighting for their lives in the neonatal intensive care unit when an echocardiogram revealed Irie had a patent ductus arteriosus (PDA) that required immediate treatment. "The doctor thought Abbott's Amplatzer Piccolo device was the best solution for Irie, and after learning more about the procedure we decided to move forward," said Crissa Felkner, Irie's mother. "You have to live it to fully appreciate what that device did for our daughter. Three days after the procedure, she was making great progress and is now a normal toddle...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news
More News: Learning | Lung Transplant | Radiology | Universities & Medical Training